Posts in category Healthcare


The World’s Top Fund Manager Jim Simons Bought a Big Chunk of Valeant Pharmaceuticals Intl Inc (VRX), Reduced Exposure to Opko Health Inc. (OPK)

Is Billionaire fund guru Jim Simons switching OPK for VRX?

Read more

Illinois’ Richest Man Ken Griffin Sees Potential Opportunities in Healthcare: Valeant Pharmaceuticals Intl Inc (VRX), Teva Pharmaceutical Industries Ltd (TEVA)

Ken Griffin is a man known to be raring to take a risk when it …

Read more

Quant King David Shaw Pours More Money Into Valeant Pharmaceuticals Intl Inc (VRX), MannKind Corporation (MNKD)

One of the world’s top fund managers is backing volatile healthcare stocks VRX and MNKD.

Read more

Dmitry Balyasny Gets Bullish on 3 Drug Makers: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Synergy Pharmaceuticals Inc (SGYP), Opko Health Inc. (OPK)

Risk-taker Dmitry Balyasny eyes advantage in the biotech world, between new initiations in TEVA, SGYP, and a major increase in OPK.

Read more

There’s More Than Meets The Eye With Calithera Biosciences

Written by Danny Cohen And Scott Matusow This past weekend at The Society for Immunotherapy …

Read more

Billionaire Israel Englander’s Surprising Q3 Moves In Biotech: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Valeant Pharmaceuticals Intl Inc (VRX), ACADIA Pharmaceuticals Inc. (ACAD)

Israel “Izzy” Englander isn’t afraid to go against the market on TEVA, VRX and ACAD.

Read more

Synergy Pharmaceutical (SGYP) on Sale Ahead of Upcoming PDUFA Date

Shares in gastrointestinal biopharma Synergy Pharmaceuticals Inc (NASDAQ:SGYP) are plunging by 30% this week, following the …

Read more

2 Stocks Under $4 With Upside: Transenterix Inc (TRXC), MannKind Corporation (MNKD)

Both TRXC and MNKD offer potentially big rewards, but at what cost?

Read more

‘Stock Market Wizard’ Michael Masters Puts His Money on Transenterix Inc (TRXC), Says Bye Bye to Gilead Sciences, Inc. (GILD)

Did this $4 billion fund make the right call on these two soaring biotechs?

Read more

Joseph Edelman’s Take on 3 Small Cap Biotech Stocks: AcelRx Pharmaceuticals Inc (ACRX), Synergy Pharmaceuticals Inc (SGYP), Antares Pharma Inc (ATRS)

This market-beating fund manager is slashing ACRX and SGYP, but upping ATRS.

Read more